Blackstone’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$70.3K Buy
+17,020
New +$57.7K ﹤0.01% 400

Other funds holding RXRX

Blackstone's RXRX Position: Q3 2026 in Review

Blackstone opened a new position in Recursion Pharmaceuticals (RXRX) in Q3 2026: 17,020 shares worth $70.3K. The stake represents ﹤0.01% of the portfolio and ranks #400 among its holdings.

354 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.

  • Blackstone held 17,020 shares of Recursion Pharmaceuticals worth $70.3K as of Q3 2026.
  • Recursion Pharmaceuticals was a new Blackstone position in Q3 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Blackstone's portfolio in Q3 2026, its #400 holding.
  • 354 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.

Based on Blackstone's 13F filing for Q3 2026, filed 16 Nov 2026.